ENZYMOTEC LTD's ticker is ENZY and the CUSIP is M4059L101. A total of 32 filers reported holding ENZYMOTEC LTD in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $33,000 | -70.3% | 5,069 | -67.9% | 0.00% | – |
| Q3 2016 | $111,000 | -37.6% | 15,789 | -25.9% | 0.00% | – |
| Q2 2016 | $178,000 | +3.5% | 21,313 | +12.1% | 0.00% | – |
| Q1 2016 | $172,000 | +4.9% | 19,015 | +13.9% | 0.00% | – |
| Q4 2015 | $164,000 | +8.6% | 16,697 | 0.0% | 0.00% | – |
| Q3 2015 | $151,000 | +10.2% | 16,697 | +1.7% | 0.00% | – |
| Q2 2015 | $137,000 | +16.1% | 16,423 | 0.0% | 0.00% | – |
| Q1 2015 | $118,000 | -5.6% | 16,423 | 0.0% | 0.00% | – |
| Q4 2014 | $125,000 | +6.8% | 16,423 | -6.6% | 0.00% | – |
| Q3 2014 | $117,000 | -64.2% | 17,581 | +45.4% | 0.00% | – |
| Q4 2013 | $327,000 | – | 12,091 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 202,962 | $5,482,000 | 1.66% |
| Visium Asset Management, LP | 690,000 | $18,637,000 | 0.37% |
| ALYDAR PARTNERS LLC | 90,000 | $2,431,000 | 0.25% |
| Paulson & Co. | 1,733,030 | $46,809,000 | 0.23% |
| GILDER GAGNON HOWE & CO LLC | 218,232 | $5,894,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 83,971 | $2,268,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 10,000 | $270,000 | 0.04% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 5,450 | $148,000 | 0.03% |
| TFS CAPITAL LLC | 9,736 | $263,000 | 0.01% |
| BLACKROCK ADVISORS LLC | 208,806 | $5,640,000 | 0.01% |